There are about 34.2 million (10.5%) people in the United States living with diabetes, and estimates suggest that 50% of these patients will develop DPN.ĭPN is caused by high blood sugar (glucose) levels that lead to nerve damage, resulting in pain and numbness in the legs, feet, and hands. Pope, MD, DABPM, FIPP, president of Evolve Restorative Center in Santa Rosa, California, in a press release.ĭiabetic neuropathy is a complication that mainly affects the nerves that connect to the feet. ' has long plagued people affected by type 1 and type 2 diabetes, often adding another area of disease management on top of their ongoing monitoring of their glucose levels to manage this challenging disease,' said Jason E.
SCS, which is a form of neurostimulation therapy that doses tissue with a certain quantity of energy to relieve pain, can now be added to the available chronic pain management strategies that avoid the use of opioids for patients with DPN. The FDA approved a spinal cord stimulation (SCS) system (Proclaim XR Abbott) for diabetic peripheral neuropathy (DPN), a condition that currently has no disease modifying treatments.
